Collaborators

Collaboration is the key to success in any type of research. It allows colleagues to exchange ideas, shift paradigms, and break barriers that operating autonomously would never breach. At Rockland, that’s why we actively pursue partnerships with leading universities, independent research laboratories, and medical organizations.

Our work with the scientific community is as broad as it is deep, utilizing our vast resources to collaborate on research needs worldwide. We work with top researchers to develop antibody reagents not currently in existence, striving to achieve far reaching scientific results through research-focused products.

Ultimately, our scientists and researchers share the same goal – high-quality reagents that are properly validated for accuracy. Rockland partners with researchers in highly reputable organizations around the world to realize groundbreaking innovation in a variety of scientific genres.

Current Collaborators

partner-img

Cytiva Life Sciences

In collaboration with Cytiva Life Sciences (formally, GE Heathcare Life Sciences), Rockland has developed and extensively validated products to provide industry professionals a complete solution that supports Host Cell Protein (HCP) risk mitigation.
partner-img

Jefferson Institute for Bioprocessing

Rockland is proud to partner with the Jefferson Institute for Bioprocessing (JIB), to provide complete and scalable bioprocessing solutions to both large and emerging biopharmaceutical companies.
partner-img

Gene Editing Institute

In partnership with the world-renowned Gene Editing Institute team at ChristianaCare, Rockland has developed revolutionary CRISPR in a Box™ Educational Kits to introduce students across the world to invaluable genomic engineering techniques in efforts to train the next generation of scientists.
partner-img

SicklED

We are pleased to support Lehigh University's SickleID project in developing low-cost sickle cell screening devices for low- to middle-income countries. Rockland's hemoglobin antibodies are critical components for SickleID lateral flow assays.
partner-img

Diagnostic Biosystems

Rockland has partnered with Diagnostic Biosystems (DBS) to offer novel immunohistochemistry antibodies, supporting reagents, and cutting-edge equipment to diagnostic and IHC researchers for the advancement of research in anatomic pathology and histology areas of research.
partner-img

Abzyme Therapeutics

As part of Rockland's family of companies, we've joined with Abzyme Therapeutics to offer their patent-pending approach for the rapid optimization of pH-dependent antibodies for safer and more effective cancer biologics.
partner-img

The Wistar Institute

Rockland has partnered with The Wistar Research Institute, to produce, validate and distribute a diverse panel of patient-derived, low-passage melanoma cell lines from freshly excised metastases. These preclinical tumor cell line models can facilitate cancer research be by identifying critical target genes and pathways enacted by genomic alterations and enabling more accurate predictions of effectiveness for novel cancer therapeutics.
partner-img

National Cancer Institute

Rockland partners with National Cancer Institute’s Center for Cancer Research, and the team has released over 100 antibodies involved in signal transduction and cancer research so far.
partner-img

LIMR

Rockland collaborates with LIMR to provide monoclonal and polyclonal antibodies, which bind biomarkers crucial for cell signaling, immune system regulation, inflammatory responses, cellular metabolism, and cancer progression.
partner-img

Wheaton

Rockland has collaborated with Wheaton on the development of the CELLine Bioreactor Flask, which can help labs cut costs while providing high quality results in a number of analyses, including Western Blot, ELISA and immunohistochemistry assays.
partner-img

Bio-Rad

Rockland Immunochemicals has collaborated with Bio-Rad to develop an enhanced multiplex fluorescent western blotting protocol. The assays produce high resolution immunoblots on PVDF membrane, providing increased visibility and profiling of low abundance proteins.
partner-img

Leica Microsystems

Rockland has collaborated with Leica Microsystems to jointly analyze the sub-cellular localization of Akt using high-resolution STED microscopy.
partner-img

Emory University

Rockland Immunochemicals and Emory University have collaborated to develop novel antibodies and antibody based tools for Cancer, Cell Signaling and Chromatin research.
partner-img

Lonza

Rockland Immunochemicals teamed up with Lonza, a global leader in life science products and services, to improve your western blot results. Lonza PAGEr™ Gels combined with Rockland’s extensive range of antibodies and antibody-based tools ensure consistent results with continual compatibility for western blot assays.
partner-img

St. Jude Children´s Research Hospital

The partnership with St. Jude Children's Research Hospital was the first of Rockland's collaborations and was integral to our development of antibodies involved in signal transduction and cancer research. The partnership combined basic and translational research, working with life science researchers to develop enhanced bioreagents, e.g. our ATM phospho S1981 antibody, to ease biomedical research.
partner-img

SAPA-GP

Rockland is a proud member and supporter of the Sino-American Pharmaceutical Professionals Association - Greater Philadelphia (SAPA-GP), one of the most active and reputable organizations that fosters the development of it's members and the general public with high-quality scientific programs and facilitates the advancement of pharmaceutical science and technology between the US and China.
partner-img

Syngene

Syngene is a supplier of gel documentation (gel doc) systems for rapid and accurate imaging and analysis of 1D gels, 2D gels, fluorescent, and chemiluminescent blots. Rockland has developed DyLight™ Multiplex Fluorescent Western Blotting Kits for use with Syngene's G:BOX Gel Imaging System or equivalent.
partner-img

Precision Biosystems

Precision Biosystem's BlotCycler combined with Rockland’s extensive range of DyLight fluorochrome conjugated secondary antibodies offer a time-saving alternative and an improved quality of results.
partner-img

Pall Life Sciences

Pall Life Sciences, a global leader in life science products and services, has teamed up with Rockland Immunochemicals to demonstrate the impact of high quality products in Western blotting.